Johan Maertens

Johan Maertens publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Johan Maertens sits on this spectrum.

Johan Maertens D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Johan Maertens sits on this spectrum.

Research.com Recognitions

• Fellow of the European Confederation of Medical Mycology (ECMM)
• Fellow of the European Confederation of Medical Mycology (ECMM)

Overview

Best Publications

• Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

  Ben De Pauw;Thomas J. Walsh;J. Peter Donnelly;David A. Stevens

  4582
  Citations

• Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

  S. Ascioglu;J. H. Rex;B. De Pauw;J. E. Bennett

  2949
  Citations

• Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

  J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach

  2750
  Citations

• Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

  Oliver A. Cornely;Johan Maertens;Drew J. Winston;John Perfect

  2119
  Citations

• Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.

  Stefan Janssens;Christophe Dubois;Jan Bogaert;Koen Theunissen

  1702
  Citations

• Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

  A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning

  1524
  Citations

• Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

  Francisco M Marty;Per Ljungman;Roy F Chemaly;Johan Maertens

  1187
  Citations

• Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.

  Thomas J Walsh;Hedy Teppler;Gerald R Donowitz;Johan A Maertens

  1177
  Citations

• Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

  Johan A. Maertens;Issam I. Raad;Kieren A. Marr;Thomas F. Patterson

  1105
  Citations

• High-dose daunorubicin in older patients with acute myeloid leukemia.

  Bob Löwenberg;Gert J. Ossenkoppele;Wim van Putten;Harry C. Schouten

  963
  Citations

• Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

  Jürgen Finke;Wolfgang A Bethge;Claudia Schmoor;Hellmut D Ottinger

  913
  Citations

• Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High–Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)

  Oliver A. Cornely;Johan Maertens;Mark Bresnik;Ramin Ebrahimi

  857
  Citations

• Galactomannan and Computed Tomography–Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility Study

  Johan Maertens;Koen Theunissen;Gregor Verhoef;Johnny Verschakelen

  828
  Citations

• Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy

  Johan Maertens;Issam Raad;George Petrikkos;Marc Boogaerts

  805
  Citations

• Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

  Johan Maertens;Jan Verhaegen;Katrien Lagrou;Johan Van Eldere

  744
  Citations

• Isavuconazole Treatment for Mucormycosis: A Single-Arm Open-Label Trial and Case-Control Analysis

  Francisco M. Marty;Luis Ostrosky-Zeichner;Oliver A. Cornely;Kathleen M. Mullane

  715
  Citations

• Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

  Jan J. Cornelissen;Wim L. J. van Putten;Leo F. Verdonck;Matthias Theobald

  635
  Citations

• Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

  Christoph Schmid;Myriam Labopin;Arnon Nagler;Martin Bornhäuser

  634
  Citations

• Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.

  Wouter Meersseman;Katrien Lagrou;Johan Maertens;Alexander Wilmer

  617
  Citations

• European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

  J Maertens;O Marchetti;R Herbrecht;O A Cornely

  595
  Citations